SVB Leerink reiterated coverage on Assembly Biosciences with a new price target
$ASMB
Biotechnology: Pharmaceutical Preparations
Health Care
SVB Leerink reiterated coverage of Assembly Biosciences with a rating of Market Perform and set a new price target of $7.00 from $8.00 previously